Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -109.13% is 13% above its 5-year average of -125.36%, around the middle of its 5-year range (-199.77%–-53.98%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.01% above its 12-month average of -153.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -109.13%.
RETURN ON INVESTED CAPITAL (ROIC)
-109.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-153.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-134.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-125.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+29.01%
CURRENT VS 3Y AVG
+18.56%
CURRENT VS 5Y AVG
+12.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.88%
median of 493 covered companies
CURRENT VS SECTOR MEDIAN
-277.87%
vs the sector median at left
Clene Inc.
Market Cap
$49.84M
Return on Invested Capital (ROIC)
-109.13%
TTM Avg
-153.71%
3Y Avg
-134.00%
5Y Avg
-125.36%
Market Cap
$51.72M
Return on Invested Capital (ROIC)
-208.76%
TTM Avg
-1171.68%
3Y Avg
-1173.13%
5Y Avg
-939.08%
Market Cap
$49.21M
Return on Invested Capital (ROIC)
-192.99%
TTM Avg
-98.03%
3Y Avg
-92.21%
5Y Avg
-72.34%
Market Cap
$51.17M
Return on Invested Capital (ROIC)
-2441.49%
TTM Avg
-1590.42%
3Y Avg
-842.10%
5Y Avg
-573.16%
Market Cap
$49.40M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
32.98%
3Y Avg
9.79%
5Y Avg
24.14%
Market Cap
$52.80M
Return on Invested Capital (ROIC)
-38.04%
TTM Avg
-22.77%
3Y Avg
-89.18%
5Y Avg
-83.00%
Market Cap
$51.23M
Return on Invested Capital (ROIC)
-157.40%
TTM Avg
-135.65%
3Y Avg
-123.35%
5Y Avg
-111.97%
Market Cap
$51.84M
Return on Invested Capital (ROIC)
-96.37%
TTM Avg
-130.40%
3Y Avg
-89.09%
5Y Avg
-69.72%
Market Cap
$52.71M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-690.86%
3Y Avg
-402.79%
5Y Avg
-302.68%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $49.84M | -109.13% | -153.71% | -134.00% | -125.36% |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | -208.76% | -1171.68% | -1173.13% | -939.08% |
| Celularity Inc. (CELU)vs › | $49.21M | -192.99% | -98.03% | -92.21% | -72.34% |
| Apollomics, Inc. (APLM)vs › | $51.17M | -2441.49% | -1590.42% | -842.10% | -573.16% |
| biote Corp. (BTMD)vs › | $49.40M | 13.63% | 32.98% | 9.79% | 24.14% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | -38.04% | -22.77% | -89.18% | -83.00% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -157.40% | -135.65% | -123.35% | -111.97% |
| INmune Bio, Inc. (INMB)vs › | $51.84M | -96.37% | -130.40% | -89.09% | -69.72% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.71M | N/A | -690.86% | -402.79% | -302.68% |
| ImageneBio Inc (IMA)vs › | $53.01M | -40.53% | -31.24% | -37.98% | -33.19% |
ROIC
-109.1%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -109.13% |
| 2026-03-31 | -123.90% |
| 2025-12-31 | -199.77% |
| 2025-09-30 | -158.81% |
| 2025-06-30 | -176.95% |
| 2025-03-31 | -158.10% |
| 2024-12-31 | -190.14% |
| 2024-09-30 | -184.62% |
| 2024-06-30 | -108.27% |
| 2024-03-31 | -100.33% |
| 2023-12-31 | -87.16% |
| 2023-09-30 | -76.39% |
| 2023-06-30 | -68.50% |
| 2023-03-31 | -139.81% |
| 2022-12-31 | -130.64% |
| 2022-09-30 | -170.16% |
| 2022-06-30 | -139.45% |
| 2022-03-31 | -107.78% |
| 2021-12-31 | -87.62% |
| 2021-09-30 | -61.03% |
| 2021-06-30 | -53.98% |
| 2021-03-31 | -51.26% |
| 2020-12-31 | -35.73% |
| 2020-09-30 | -34.81% |
| 2020-06-30 | -186.90% |
| 2019-12-31 | -115.66% |
